Zura Bio Limited logo ZURA - Zura Bio Limited

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 5
HOLD 1
SELL 0
STRONG
SELL
0
| PRICE TARGET: $15.00 DETAILS
HIGH: $15.00
LOW: $15.00
MEDIAN: $15.00
CONSENSUS: $15.00
UPSIDE: 180.37%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1
Revenue
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 0.0 0 0 0 0 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit (0.0) 0 0 0 0 (0.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
R&D Expenses 14.7 11.0 11.9 8.7 10.5 9.2 6.0 5.5 3.6 6.9 4.0 28.2 4.9 23.2 0.4 0.1 7.5 0 0 0 0
SG&A Expenses 10.8 7.5 7.6 9.4 8.8 6.5 13.3 6.2 4.8 3.9 6.2 5.7 2.8 1.6 0.7 0.8 0.4 0.5 0.3 0.0 0.2
Other Expenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 25.5 18.4 19.5 18.1 19.3 15.7 19.3 11.8 8.4 10.8 10.2 33.9 7.7 24.8 1.1 0.9 0.4 0.5 0.3 0.0 0.2
Operating Income
Operating Income (25.5) (18.4) (19.5) (18.1) (19.3) (15.7) (19.3) (11.8) (8.4) (10.8) (10.2) (33.9) (7.7) (24.8) (1.1) (0.9) (0.4) (0.5) (0.3) (0.0) (0.2)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest Income 1.3 1.3 1.5 1.7 1.8 2.1 2.5 2.2 1.2 1.4 0.8 0 0.0 (0.0) 0 0 0.0 0.0 0.0 0 0.0
Profitability
EBITDA (24.2) (17.2) (18.0) (16.0) (17.4) (13.6) (20.7) (10.3) (7.7) (8.5) (8.3) (33.9) (9.8) (25.3) (1.1) (0.9) 0.1 0.8 5.8 (0.0) 1.8
EBIT (24.2) (17.2) (18.0) (16.0) (17.4) (13.6) (20.7) (10.3) (7.7) (8.5) (8.3) (34.0) (9.8) (25.3) (1.1) (0.9) 0.1 0.8 5.8 (0.0) 1.8
Income Before Tax (24.2) (17.2) (18.0) (16.0) (17.4) (13.6) (20.7) (10.3) (7.7) (8.5) (8.3) (34.0) (9.8) (25.5) (1.1) (0.9) 0.1 0.8 5.8 (0.0) 1.8
Income Tax Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (24.2) (17.2) (18.0) (16.0) (17.4) (9.0) (20.7) (10.3) (7.7) (8.5) (8.3) (34.0) (9.6) (23.9) (1.1) (0.9) 0.1 0.8 5.8 (0.0) 1.8
Per Share Data
EPS (Basic) -0.22 -0.49 -0.21 -0.17 -0.19 -0.14 -0.26 -0.17 -0.02 -0.18 -0.18 -0.99 -0.27 0.32 -0.06 -0.05 0.01 0.05 0.34 -0.00 0.01
EPS (Diluted) -0.22 -0.49 -0.21 -0.17 -0.27 -0.14 -0.26 -0.17 -0.02 -0.18 -0.18 -0.99 -0.27 0.32 -0.06 -0.05 0.01 0.05 0.34 -0.00 0.01
Shares Outstanding 112.2 94.2 94.6 94.3 65.3 65.3 87.3 74.9 46.9 47.0 46.9 34.3 35.5 17.2 17.2 17.2 17.2 17.2 17.2 17.2 17.2
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2
Current Assets
Cash & Cash Equivalents 225.6 109.4 139.0 154.5 170.6 176.5 188.2 188.4 89.8 99.8 103.9 112.8 44.0 1.6 3.0 4.4 4.7 0.7 1.0 0.0
Short-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Receivables 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 1.4 2.9 3.3 2.5 1.1 2.2 0.8 1.0 0.7 1.0 0.7 0.5 0 0.2 0 1.2 0 0 0 0
Total Current Assets 227.0 112.3 142.3 157.0 171.7 178.7 189.0 189.5 90.5 100.8 104.6 113.3 44.4 1.8 3.3 5.6 4.7 1.2 1.5 0.0
Non-Current Assets
Property, Plant & Equipment 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 139.4 139.4 0
Other Non-Current Assets 1.5 1.5 1.5 0.7 0.7 0.7 0.1 0 0 0 0 0 0 3.5 1.9 0 0 0 0 0.1
Total Non-Current Assets 1.6 1.6 1.6 0.8 0.8 0.8 0.1 0.0 0.0 0 0 0 0 3.5 1.9 0 0 139.4 139.4 0.1
Total Assets 228.6 113.9 143.9 157.8 172.5 179.5 189.1 189.5 90.5 100.8 104.6 113.3 44.4 5.3 5.2 5.6 4.7 140.6 140.9 0.2
Current Liabilities
Account Payables 2.1 1.3 3.3 1.2 1.2 0.7 1.0 1.0 1.5 2.7 1.6 7.1 2.4 2.0 1.1 0.2 0 0 0 0
Short-Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 7.8 0 0 0 0 0 0.1
Deferred Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 1.1 3.3 7.2 1.4 0.7 18.8 1.4 12.6 0.4 1.2 15.0 0.6 0.9 2.8 0 0.1 0.0 0.3 0.1 0.1
Total Current Liabilities 11.7 12.4 25.5 18.7 21.1 19.5 18.2 15.1 14.7 20.3 17.0 19.9 5.0 14.8 2.2 1.5 0.0 0.3 0.1 0.2
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 2.4 1.6 1.0 1.9 2.1 1.5 12.5 12.5 12.5 12.5 10.1 11.7 0
Total Non-Current Liabilities 0 0 0 0 0 0 0 2.4 1.6 1.0 1.9 2.1 1.5 12.5 12.5 12.5 12.5 10.1 11.7 0
Total Liabilities 11.7 12.4 25.5 18.7 21.1 19.5 18.2 17.4 16.3 21.3 19.0 22.0 6.5 27.3 14.7 14.0 12.5 10.4 11.8 0.2
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0 0 0 139.4 139.4 0.0
Retained Earnings (248.8) (224.5) (207.4) (189.3) (173.3) (155.9) (142.3) (121.6) (111.2) (103.5) (95.0) (86.8) (41.9) (32.1) (9.8) (8.7) (7.8) (9.2) (10.3) (0.1)
Accumulated Other Comprehensive Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Stockholders' Equity 216.9 101.5 108.2 125.9 138.2 146.8 153.0 156.5 61.0 59.3 63.2 68.9 27.9 (32.1) (9.5) (8.4) (7.8) 130.2 129.1 (0.0)
Total Liabilities & Equity 228.6 113.9 143.9 157.8 172.5 179.5 189.1 189.5 90.5 100.8 104.6 113.3 44.4 5.3 5.2 5.6 4.7 140.6 140.9 0.2
Debt Metrics
Total Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 7.8 0 0 0 0 0 0.1
Net Debt (225.6) (109.4) (139.0) (154.5) (170.6) (176.5) (188.2) (188.4) (89.8) (99.8) (103.9) (112.8) (44.0) 6.2 (3.0) (4.4) (4.7) (0.7) (1.0) 0.1
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3
Operating Activities
Net Income (24.2) (17.2) (20.0) (16.0) (17.4) (11.3) (20.7) (12.7) (7.7) (8.5) (8.3) (34.0) (9.8) 0.5 2.3 0.1 0.8 5.8
Depreciation & Amortization 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0 0 0 0 0 0 0 0 0 0
Stock-Based Compensation 5.0 2.6 0 3.7 3.6 2.8 8.6 2.9 2.4 2.4 2.6 2.3 2.4 0 0 0 0 0
Change in Working Capital 0.3 (2.7) 0.2 (3.8) 2.7 (0.0) 2.5 0.0 (0.2) 3.0 2.8 (1.0) 0.2 0.3 0.6 0.2 0.3 (0.5)
Other Non-Cash Items 0.0 (5.0) 4.4 0.0 0.0 (2.3) 3.9 3.1 0.6 (1.0) 0.3 27.5 3.9 (1.0) (3.3) (0.6) (1.3) (6.1)
Operating Cash Flow (18.9) (22.3) (15.4) (16.0) (11.1) (10.8) (5.7) (6.6) (5.0) (4.1) (2.6) (5.2) (3.3) (0.3) (0.5) (0.2) (0.3) (0.9)
Investing Activities
Capital Expenditure (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (5.0) 0 (2.2) (5.8) 0 (0.0) (0.0) 0 0.0 (0.0)
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (139.4)
Sales/Maturities of Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 (5) 0 0 (5) 0 0 0 0 0 0 0 0 0
Investing Cash Flow (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (5.0) 0 (2.2) (5.8) 0 0 0 0 0 (139.4)
Financing Activities
Net Debt Issuance 0 0 (0.1) 0 0.1 0 0 0 0 0 0 0 (10) 0.1 0.2 0 0 (0.1)
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 (7.3) 0 (0.0) 0 59.9 (0.1) 50.0 0 0 0 15.9 (1.0) 0 0 0 0 0.5
Financing Cash Flow 135.1 (7.3) 0.0 (0.0) 5.2 (0.9) 5.4 105.3 0 0 (4.1) 79.8 45.7 0.1 0.2 0 0 141.2
Cash Position
Net Change in Cash 116.2 (29.6) (15.5) (16.1) (5.9) (11.7) (0.2) 98.6 (10.0) (4.1) (8.9) 68.8 42.4 (0.1) (0.3) (0.2) (0.3) 1.0
Cash at Beginning 109.4 139.0 154.5 170.6 176.5 188.2 188.4 89.8 99.8 103.9 112.8 44.0 1.6 0.2 0.5 0.7 1.0 0.0
Cash at End 225.6 109.4 139.0 154.5 170.6 176.5 188.2 188.4 89.8 99.8 103.9 112.8 44.0 0.1 0.2 0.5 0.7 1.0
Free Cash Flow (18.9) (22.3) (15.5) (16.0) (11.1) (10.9) (5.7) (6.6) (10.0) (4.1) (4.8) (10.9) (3.3) (0.3) (0.5) (0.2) (0.3) (0.9)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1
Income Statement
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit (0.0) 0 0 0 0 (0.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Income (25.5) (18.4) (19.5) (18.1) (19.3) (15.7) (19.3) (11.8) (8.4) (10.8) (10.2) (33.9) (7.7) (24.8) (1.1) (0.9) (0.4) (0.5) (0.3) (0.0) (0.2)
Net Income (24.2) (17.2) (18.0) (16.0) (17.4) (9.0) (20.7) (10.3) (7.7) (8.5) (8.3) (34.0) (9.6) (23.9) (1.1) (0.9) 0.1 0.8 5.8 (0.0) 1.8
EPS (Diluted) -0.22 -0.49 -0.21 -0.17 -0.27 -0.14 -0.26 -0.17 -0.02 -0.18 -0.18 -0.99 -0.27 0.32 -0.06 -0.05 0.01 0.05 0.34 -0.00 0.01
Balance Sheet
Cash & Equivalents 225.6 109.4 139.0 154.5 170.6 176.5 188.2 188.4 89.8 99.8 103.9 112.8 44.0 1.6 3.0 4.4 4.7 0.7 1.0 0.0
Total Assets 228.6 113.9 143.9 157.8 172.5 179.5 189.1 189.5 90.5 100.8 104.6 113.3 44.4 5.3 5.2 5.6 4.7 140.6 140.9 0.2
Total Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 7.8 0 0 0 0 0 0.1
Stockholders' Equity 216.9 101.5 108.2 125.9 138.2 146.8 153.0 156.5 61.0 59.3 63.2 68.9 27.9 (32.1) (9.5) (8.4) (7.8) 130.2 129.1 (0.0)
Cash Flow
Operating Cash Flow (18.9) (22.3) (15.4) (16.0) (11.1) (10.8) (5.7) (6.6) (5.0) (4.1) (2.6) (5.2) (3.3) (0.3) (0.5) (0.2) (0.3) (0.9)
Capital Expenditure (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (0.0) (5.0) 0 (2.2) (5.8) 0 (0.0) (0.0) 0 0.0 (0.0)
Free Cash Flow (18.9) (22.3) (15.5) (16.0) (11.1) (10.9) (5.7) (6.6) (10.0) (4.1) (4.8) (10.9) (3.3) (0.3) (0.5) (0.2) (0.3) (0.9)